Loading
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.
Latest quote
$19.73
−$0.80 · -3.90%
After-hours
$19.73
$0.00 · 0.00%
Nov 4, 4:10 PM ET
Regular session · ET · Market data may be delayed.
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.
Day range
Current $19.73
52-week range
Current $19.73
Regular session · ET · Market data may be delayed.
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.
Day range
Current $19.73
52-week range
Current $19.73
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Extended Market ETFVXF1.62M0.00%30.2B USD0.05%$233.44+0.77%
Vanguard Russell 2000 ETFVTWO119.97K0.00%16.6B USD0.06%$114.65+1.46%
Vanguard Russell 2000 Growth ETFVTWG11.87K0.00%1.4B USD0.06%$260.31+1.27%
Vanguard Russell 2000 Value ETFVTWV4.47K0.00%1.3B USD0.06%$192.85+1.77%
Vanguard Russell 3000 ETFVTHR1.85K0.00%4.9B USD0.06%$337.75+1.55%Vanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOVanguard Russell 2000 Growth ETFVTWGVanguard Russell 2000 Value ETFVTWVVanguard Russell 3000 ETFVTHRAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
